Novo Nordisk A/S ( NONOF) - Key Metrics
NONOF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $17.73 | $4.74 | $12.47 | $9.57 |
| 2026Q1 | $21.79 | $10.93 | $5.42 | $2.71 |
| 2025Q4 | $17.77 | $6.04 | $1.71 | -$2.43 |
| 2025Q3 | $16.86 | $4.50 | $10.37 | $7.31 |
| 2025Q2 | $17.28 | $5.96 | $9.17 | $5.51 |
NONOF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 16.35 |
| 2026Q1 | 72.72% | 5.30 |
| 2025Q4 | 0% | 13.44 |
| 2025Q3 | 83.29% | 19.47 |
| 2025Q2 | 0.66% | 18.45 |
NONOF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 3.09% | 0% |
| 2026Q1 | 1.17% | 3.43% |
| 2025Q4 | -0.75% | 0% |
| 2025Q3 | 2.08% | 1.07% |
| 2025Q2 | 1.25% | 0.01% |
NONOF
Price: $38.15
Dividend Yield: 4.85%
Forward Dividend Yield: 3.05%
Payout Ratio: 34.62%
Dividend Per Share: 1.16 USD
Earnings Per Share: 4.05 USD
P/E Ratio: 11.58
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Denmark
Market Capitalization: 164.8 billion
Average Dividend Frequency: 2
Years Paying Dividends: 18
DGR3: 30.00%
DGR5: 24.25%
DGR10: 21.21%